These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

819 related articles for article (PubMed ID: 26767305)

  • 1. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
    Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
    ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intercellular adhesion molecule 1 antibody-mediated mesoporous drug delivery system for targeted treatment of triple-negative breast cancer.
    Wang M; Liu W; Zhang Y; Dang M; Zhang Y; Tao J; Chen K; Peng X; Teng Z
    J Colloid Interface Sci; 2019 Mar; 538():630-637. PubMed ID: 30554096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
    Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
    Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionalization of mesoporous organosilica nanocarrier for pH/glutathione dual-responsive drug delivery and imaging of cancer therapy process.
    Hu LL; Meng J; Zhang DD; Chen ML; Shu Y; Wang JH
    Talanta; 2018 Jan; 177():203-211. PubMed ID: 29108577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional nanosheets based on folic acid modified manganese oxide for tumor-targeting theranostic application.
    Hao Y; Wang L; Zhang B; Zhao H; Niu M; Hu Y; Zheng C; Zhang H; Chang J; Zhang Z; Zhang Y
    Nanotechnology; 2016 Jan; 27(2):025101. PubMed ID: 26629735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
    Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
    Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facile Synthesis of Yolk-Shell-Structured Triple-Hybridized Periodic Mesoporous Organosilica Nanoparticles for Biomedicine.
    Teng Z; Zhang J; Li W; Zheng Y; Su X; Tang Y; Dang M; Tian Y; Yuwen L; Weng L; Lu G; Wang L
    Small; 2016 Jul; 12(26):3550-8. PubMed ID: 27183872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tri-stimuli-responsive biodegradable theranostics for mild hyperthermia enhanced chemotherapy.
    Lu N; Huang P; Fan W; Wang Z; Liu Y; Wang S; Zhang G; Hu J; Liu W; Niu G; Leapman RD; Lu G; Chen X
    Biomaterials; 2017 May; 126():39-48. PubMed ID: 28254692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication of multifunctional triple-responsive platform based on CuS-capped periodic mesoporous organosilica nanoparticles for chemo-photothermal therapy.
    Cheng X; Li D; Lin A; Xu J; Wu L; Gu H; Huang Z; Liu J; Zhang Y; Yin X
    Int J Nanomedicine; 2018; 13():3661-3677. PubMed ID: 29983561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
    Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
    Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Facile preparation of near-infrared fluorescence and magnetic resonance dual-modality imaging probes based on mesoporous organosilica nanoparticles.
    Li Y; Guo W; Su X; Lu N; Wu G; Ou-Yang L; Dang M; Tao J; Teng Z
    J Colloid Interface Sci; 2019 Mar; 539():277-286. PubMed ID: 30590235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
    Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
    Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetically modified-mitoxantrone mesoporous organosilica drugs: an emergent multimodal nanochemotherapy for breast cancer.
    Romaní-Cubells E; Martínez-Erro S; Morales V; Chocarro-Calvo A; García-Martínez JM; Sanz R; García-Jiménez C; García-Muñoz RA
    J Nanobiotechnology; 2024 May; 22(1):249. PubMed ID: 38745193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodic Mesoporous Organosilica Nanoparticles with Controlled Morphologies and High Drug/Dye Loadings for Multicargo Delivery in Cancer Cells.
    Croissant JG; Fatieiev Y; Omar H; Anjum DH; Gurinov A; Lu J; Tamanoi F; Zink JI; Khashab NM
    Chemistry; 2016 Jul; 22(28):9607-15. PubMed ID: 27245497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin and doxorubicin high-loaded nanodrug based on biocompatible thioether- and ethane-bridged hollow mesoporous organosilica nanoparticles.
    Zhang J; Weng L; Su X; Lu G; Liu W; Tang Y; Zhang Y; Wen J; Teng Z; Wang L
    J Colloid Interface Sci; 2018 Mar; 513():214-221. PubMed ID: 29153715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-Targeting Multifunctional Rattle-Type Theranostic Nanoparticles for MRI/NIRF Bimodal Imaging and Delivery of Hydrophobic Drugs.
    Jiao Y; Sun Y; Tang X; Ren Q; Yang W
    Small; 2015 Apr; 11(16):1962-74. PubMed ID: 25504837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabrication of ultrasmall WS
    Liao W; Zhang L; Zhong Y; Shen Y; Li C; An N
    Onco Targets Ther; 2018; 11():1949-1960. PubMed ID: 29670370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
    Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
    Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photo-responsive degradable hollow mesoporous organosilica nanoplatforms for drug delivery.
    Fan J; Zhang Z; Wang Y; Lin S; Yang S
    J Nanobiotechnology; 2020 Jun; 18(1):91. PubMed ID: 32539777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.